MDGL

Madrigal Pharmaceuticals, Inc. · NASDAQ

Sector Health Technology
Industry Pharmaceuticals: Major
Website madrigalpharma.com
Employees(FY) 92
ISIN US5588681057

Performance

-3.91%

-13.4%

+10.58%

+39.92%

-2.24%

YTD

+32.11%

Profile

Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of non-alcoholic steatohepatitis (NASH) in the United States. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor beta agonist, which is in Phase III clinical trials for treating NASH. The company is also developing MGL-3745, a backup compound to resmetirom. The company is headquartered in West Conshohocken, Pennsylvania.

Advanced Technical Analysis

Technical Analysis of MDGL 2025-04-17

The stock indicators reflect a bearish sentiment overall, with the Moving Average Score at 16 and the Technical Score at 30, both indicating weakness, while the Oscillators Score at 45 suggests a neutral stance. This combination implies a lack of strong bullish momentum, signaling caution for potential investors.

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of MDGL

Stock Rank

Recent News & Updates

2025-03-20 20:30
Artisan International Small-Mid Fund Q4 2024 Commentary(Seekingalpha)
2025-03-19 10:34
Tracking John Paulson's Paulson & Co. Portfolio - Q4 2024 Update(Seekingalpha)
2025-03-17 17:28
Madrigal Pharmaceuticals (MDGL): Among the Best Biotech Stocks to Buy According to Billionaires(Yahoo Finance)
2025-03-10 20:00
Madrigal Appoints Jacqualyn A. Fouse, Ph.D. to Its Board of Directors(Globenewswire)
2025-03-06 16:35
Goldman Sachs Says Its Time to Pull the Trigger on Healthcare Stocks Here Are 2 Names to Pounce on Now(Yahoo Finance)
2025-02-27 21:20
Madrigal Pharmaceuticals price target raised to $239 from $154 at BofA(Yahoo Finance)
2025-02-26 13:05
Madrigal Pharmaceuticals Inc (MDGL) Q4 2024 Earnings Call Highlights: Strong Sales Growth and ...(Yahoo Finance)
2025-02-26 10:43
Q4 2024 Madrigal Pharmaceuticals Inc Earnings Call(Yahoo Finance)
2025-02-25 23:28
Madrigal Pharmaceuticals Stock Jumps On New Two-Year Data Showing Potential Benefit of Rezdiffra For Compensated Fatty Liver Cirrhosis(Yahoo Finance)
2025-02-25 22:27
Why Madrigal Pharmaceuticals Stock Is Soaring Today(Yahoo Finance)
2025-02-25 18:21
Madrigal: Q4 Earnings Snapshot(Yahoo Finance)
2025-02-25 18:00
Madrigal Pharmaceuticals Reports Fourth-Quarter and Full-Year 2024 Financial Results and Announces New Two-Year Data Demonstrating Potential Benefit of Rezdiffra (resmetirom) in Patients with Compensated MASH Cirrhosis(Globenewswire)
2025-02-25 17:30
Madrigal Announces New Two-Year Data from the Compensated MASH Cirrhosis Arm of the MAESTRO-NAFLD-1 Trial Demonstrating Potential Benefit of Rezdiffra (resmetirom) in Patients with Compensated MASH Cirrhosis(Globenewswire)
2025-02-20 19:00
Madrigal Pharmaceuticals to Participate in the 45th Annual TD Cowen Health Care Conference(Globenewswire)
2025-02-12 08:00
Madrigal Pharmaceuticals to Release Fourth-Quarter and Full-Year 2024 Financial Results and Host Webcast on February 26, 2025(GlobeNewswire)
2025-02-11 19:00
Madrigal Pharmaceuticals to Release Fourth-Quarter and Full-Year 2024 Financial Results and Host Webcast on February 26, 2025(Globenewswire)
2025-01-28 06:20
Daily – Vickers Top Buyers & Sellers for 01/28/2025(Argus Research)
2025-01-27 17:15
Madrigal Pharmaceuticals Insider Sold Shares Worth $531,020, According to a Recent SEC Filing(MT Newswires)
2025-01-23 13:02
Exploring Three High Growth Tech Stocks in the United States(Simply Wall St.)
2025-01-21 06:18
Daily – Vickers Top Buyers & Sellers for 01/21/2025(Argus Research)
2025-01-17 08:28
Why Madrigal Pharmaceuticals Stock Was Plummeting This Week(Motley Fool)
2025-01-15 09:41
MDGL Stock Down 10% on Disappointing Preliminary Q4 Rezdiffra Sales(Zacks)
2025-01-13 12:19
Update: Madrigal Pharmaceuticals Shares Decline After Posting Preliminary Q4 Rezdiffra Net Sales of Up to $103 Million(MT Newswires)
2025-01-13 11:20
Why Madrigal Pharmaceuticals Stock Is Sinking Today(Motley Fool)
2025-01-13 08:26
Madrigal Pharmaceuticals Reports Preliminary Q4 Rezdiffra Net Sales of Up to $103 Million(MT Newswires)
2025-01-13 06:45
Madrigal Pharmaceuticals Announces Preliminary* Fourth-Quarter and Full-Year 2024 Net Sales, Year-End Cash and Total Patients on Rezdiffra(GlobeNewswire)
2025-01-12 17:45
Madrigal Pharmaceuticals Announces Preliminary* Fourth-Quarter and Full-Year 2024 Net Sales, Year-End Cash and Total Patients on Rezdiffra(Globenewswire)
2025-01-03 08:00
Madrigal Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference(GlobeNewswire)
2025-01-02 19:00
Madrigal Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference(Globenewswire)
2024-12-25 09:02
Exploring Three High Growth Tech Stocks In The United States(Simply Wall St.)

Page 1 of 5

previousnext

Disclaimer: The information provided here and on kavout.com is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout makes no recommendations regarding investment decisions based on this information. You are solely responsible for your investments. Please conduct your own research and consult qualified financial advisors before investing. Past performance does not guarantee future results.